Intercept's NASH drug fails late-stage trial, shares tumble https://ift.tt/j1SmHqO

Non-alcoholic steatohepatitis is a serious progressive liver disease that is one of the fastest-growing causes of liver transplant and does not have any FDA-approved treatments. It causes fibrosis, an earlier stage of scarring that leads to the buildup of scar tissue, cirrhosis in its advanced stages and serious liver diseases such as cancer.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/s9BXR6Q